90Y-DOTA-hLL2 (501423-25-2)
| Identification |
| Properties |
| Safety Data |
| |
 |
Other Product
- Gadolinium-DOTA
- DOTA-BIM-23014:DOTA-Lanreotide
- DOTA-NOC, DOTA-[Nal3]-octreotide
- (90Y)yttrium citrate
- Iron DOTA Sodium Salt
- gadolinium DOTA meglumine
- DOTA-cyclo(RGDfK) acetate
- DOTA-tris-tBu-ester NHS
- Yttrate(5-)-90Y,[[[1,2-ethanediylbis[nitrilobis(methylene)]]tetrakis[phosphonato]](8-)-N,N',OP,OP',OP'',OP''']-,(OC-6-21)- (9CI)
- Immunoglobulin G1, anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 gamma-chain), disulfide with human-mouse monoclonal hMN-14 kappa-chain, dimer, yttrium-90Y chelate
- Immunoglobulin G1, anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 gamma-chain), disulfide with human-mouse monoclonal hMN-14 kappa-chain, dimer, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate, yttrium-90Y chelate
